Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 22 01:59PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.38 Insider Own7.22% Shs Outstand16.82M Perf Week-9.19%
Market Cap5.47M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float15.61M Perf Month-27.79%
Income-6.35M PEG- EPS next Q- Inst Own23.17% Short Float0.50% Perf Quarter-55.50%
Sales5.41M P/S1.01 EPS this Y- Inst Trans16.31% Short Ratio0.32 Perf Half Y-64.29%
Book/sh0.46 P/B0.70 EPS next Y- ROA-68.45% Short Interest0.08M Perf Year-76.45%
Cash/sh0.32 P/C1.03 EPS next 5Y- ROE-92.06% 52W Range0.28 - 2.13 Perf YTD-74.00%
Dividend Est.- P/FCF- EPS past 5Y-24.30% ROI-76.03% 52W High-84.74% Beta-1.08
Dividend TTM- Quick Ratio3.37 Sales past 5Y31.67% Gross Margin11.41% 52W Low16.07% ATR (14)0.04
Dividend Ex-Date- Current Ratio4.44 EPS Y/Y TTM29.86% Oper. Margin-123.51% RSI (14)23.71 Volatility7.79% 12.72%
Employees62 Debt/Eq0.11 Sales Y/Y TTM-43.30% Profit Margin-117.46% Recom1.00 Target Price13.00
Option/ShortYes / Yes LT Debt/Eq0.07 EPS Q/Q6.86% Payout- Rel Volume0.10 Prev Close0.33
Sales Surprise- EPS Surprise- Sales Q/Q-8.50% Earnings- Avg Volume245.29K Price0.32
SMA20-20.39% SMA50-37.48% SMA200-60.91% Trades Volume17,886 Change-2.29%
Date Action Analyst Rating Change Price Target Change
Nov-10-20Initiated Colliers Securities Buy $13
Jan-04-18Initiated B. Riley FBR, Inc. Buy $7.50
Jul-16-24 07:43AM
Jul-01-24 07:47AM
May-13-24 08:19AM
Apr-29-24 11:33AM
07:47AM Loading…
Apr-15-24 07:47AM
Apr-12-24 10:52PM
Mar-28-24 08:19AM
Feb-21-24 08:19AM
Jan-23-24 08:19AM
Jan-16-24 02:51PM
Dec-20-23 08:30AM
Dec-18-23 07:47AM
08:19AM Loading…
Nov-10-23 08:19AM
Nov-08-23 08:19AM
Oct-13-23 01:10PM
Sep-26-23 08:19AM
Sep-22-23 03:05PM
Aug-28-23 08:19AM
Aug-25-23 05:00PM
Aug-03-23 08:19AM
Jun-21-23 08:19AM
May-18-23 08:19AM
Apr-17-23 07:47AM
Apr-14-23 04:48PM
Mar-08-23 08:19AM
Mar-07-23 04:39PM
07:30AM Loading…
Mar-03-23 07:30AM
Mar-02-23 05:15PM
Feb-20-23 05:57AM
Jan-23-23 06:00AM
Jan-13-23 06:39PM
Jan-10-23 08:19AM
Dec-08-22 08:19AM
Dec-01-22 05:12AM
Nov-02-22 08:19AM
Oct-14-22 10:24AM
Oct-13-22 04:50PM
Oct-11-22 06:25AM
Sep-29-22 08:19AM
Aug-31-22 06:25AM
Aug-30-22 08:19AM
Aug-29-22 04:41PM
Jul-14-22 11:50AM
Jun-23-22 08:19AM
May-16-22 01:20PM
May-12-22 08:19AM
Apr-26-22 08:19AM
Apr-14-22 08:37AM
Feb-08-22 12:27PM
Jan-13-22 08:19AM
Dec-16-21 08:19AM
Dec-03-21 04:32AM
Nov-19-21 08:19AM
Nov-04-21 06:39AM
Oct-29-21 08:19AM
Oct-19-21 06:39AM
Oct-15-21 06:39AM
Oct-12-21 06:11AM
Oct-04-21 04:30PM
Oct-01-21 02:51PM
Aug-30-21 08:19AM
Aug-13-21 01:50AM
Aug-11-21 08:19AM
Aug-05-21 08:19AM
Jul-08-21 11:20AM
Jun-24-21 08:19AM
Jun-23-21 06:53PM
Jun-15-21 08:19AM
Jun-11-21 02:16AM
Jun-04-21 08:00AM
May-27-21 07:15PM
May-12-21 08:30AM
May-11-21 04:38PM
Apr-20-21 09:35AM
Apr-15-21 10:31AM
Apr-07-21 02:33AM
Feb-17-21 12:23AM
Jan-15-21 09:27AM
Jan-13-21 10:26AM
Jan-12-21 08:19AM
Jan-03-21 02:06AM
Dec-16-20 07:05AM
Dec-09-20 08:19AM
Oct-16-20 09:27AM
Oct-05-20 07:16AM
Sep-01-20 08:19AM
Aug-31-20 05:00PM
Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The firm focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, United States, Asia, South America, Middle East, and Other. The company was founded in September 1971 and is headquartered in Irvine, CA.